Directly targeting the body’s endo-cannabinoid system may slow down or stop bone erosion in Rheumatiod Arthritis, according to researchers at the Children’s Hospital of Soochow University in Suzhou, China.
The experimental research, using laboratory mice, found that some of the cannabinoid receptors in the body don’t work properly.
Certain cannabinoids that are naturally produced in the body (endo-cannabinoids) were “activated” and then applied to the deficient receptors.
“Many members of the endocannabinoid system are reported to inhibit synovial inflammation, hyperplasia, and cartilage destruction in RA,” says the study.
The endocannabinoid system and its therapeutic implications in rhuematoid arthritis was published in the International Immunopharmacology journal in May 2015.